Bayer Ag Stock Today
| BAYZF Stock | USD 25.33 1.12 4.63% |
PerformanceGood
| Odds Of DistressLow
|
Bayer AG is trading at 25.33 as of the 26th of March 2025. This is a 4.63 percent increase since the beginning of the trading day. The stock's lowest day price was 25.32. Bayer AG has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Ag is traded on OTC Exchange in the United States. The company has 982.42 M outstanding shares. More on Bayer AG
Moving together with Bayer Pink Sheet
| 0.61 | LLY | Eli Lilly | PairCorr |
| 0.91 | JNJ | Johnson Johnson | PairCorr |
| 0.9 | RHHBF | Roche Holding AG | PairCorr |
| 0.94 | RHHBY | Roche Holding | PairCorr |
| 0.95 | RHHVF | Roche Holding AG | PairCorr |
Moving against Bayer Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bayer Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Bayer AG [BAYZF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 64.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bayer AG's market, we take the total number of its shares issued and multiply it by Bayer AG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bayer AG classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 982.42 M outstanding shares.
Bayer AG has accumulated about 8.19 B in cash with 5.09 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.34.
Check Bayer AG Probability Of Bankruptcy
Ownership AllocationBayer AG holds a total of 982.42 Million outstanding shares. 30% of Bayer AG outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bayer Ownership Details
Bayer AG Risk Profiles
| Mean Deviation | 1.7 | |||
| Semi Deviation | 1.7 | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.56 |
Bayer Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bayer AG without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Bayer AG Corporate Management
| Sarena Lin | Labor Officer | Profile | |
| Oliver Maier | Head Relations | Profile | |
| Gabriel Harnier | Patents Law | Profile | |
| Heiko Schipper | Member of the Management Board, Head of the Consumer Health Division | Profile | |
| Rodrigo Santos | Member Division | Profile | |
| Michael Preuss | Gov Communications | Profile | |
| Stefan Oelrich | Member of the Management Board, Head of the Pharmaceuticals Division | Profile |
Other Information on Investing in Bayer Pink Sheet
Bayer AG financial ratios help investors to determine whether Bayer Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.